Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Finished Goods (2022 - 2025)

Historic Finished Goods for Ekso Bionics Holdings (EKSO) over the last 4 years, with Q3 2025 value amounting to $943000.0.

  • Ekso Bionics Holdings' Finished Goods rose 1599.02% to $943000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $943000.0, marking a year-over-year increase of 1599.02%. This contributed to the annual value of $843000.0 for FY2024, which is 8246.75% up from last year.
  • As of Q3 2025, Ekso Bionics Holdings' Finished Goods stood at $943000.0, which was up 1599.02% from $1.1 million recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Finished Goods high stood at $1.1 million for Q2 2025, and its period low was $462000.0 during Q4 2023.
  • For the 4-year period, Ekso Bionics Holdings' Finished Goods averaged around $818454.5, with its median value being $843000.0 (2024).
  • In the last 5 years, Ekso Bionics Holdings' Finished Goods crashed by 4646.58% in 2023 and then surged by 8246.75% in 2024.
  • Over the past 4 years, Ekso Bionics Holdings' Finished Goods (Quarter) stood at $863000.0 in 2022, then plummeted by 46.47% to $462000.0 in 2023, then surged by 82.47% to $843000.0 in 2024, then rose by 11.86% to $943000.0 in 2025.
  • Its Finished Goods stands at $943000.0 for Q3 2025, versus $1.1 million for Q2 2025 and $911000.0 for Q1 2025.